ATE341326T1 - Ophthalmische zubereitung mit ascomycin - Google Patents

Ophthalmische zubereitung mit ascomycin

Info

Publication number
ATE341326T1
ATE341326T1 AT03711914T AT03711914T ATE341326T1 AT E341326 T1 ATE341326 T1 AT E341326T1 AT 03711914 T AT03711914 T AT 03711914T AT 03711914 T AT03711914 T AT 03711914T AT E341326 T1 ATE341326 T1 AT E341326T1
Authority
AT
Austria
Prior art keywords
ascomycin
ophthalmic preparation
ophthalmic
preparation
Prior art date
Application number
AT03711914T
Other languages
English (en)
Inventor
Saunier Maggy Babiole
Jean-Claude Bizec
Michelle Pik-Han Wong
Shau-Fong Yen
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE341326(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE341326T1 publication Critical patent/ATE341326T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT03711914T 2002-03-04 2003-03-03 Ophthalmische zubereitung mit ascomycin ATE341326T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US40927502P 2002-09-09 2002-09-09

Publications (1)

Publication Number Publication Date
ATE341326T1 true ATE341326T1 (de) 2006-10-15

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03711914T ATE341326T1 (de) 2002-03-04 2003-03-03 Ophthalmische zubereitung mit ascomycin

Country Status (27)

Country Link
US (4) US20050220823A1 (de)
EP (1) EP1482936B1 (de)
JP (1) JP4740542B2 (de)
KR (1) KR100992948B1 (de)
CN (1) CN1297270C (de)
AR (1) AR038628A1 (de)
AT (1) ATE341326T1 (de)
AU (1) AU2003218679B2 (de)
BR (1) BR0308184A (de)
CA (1) CA2477769C (de)
CO (1) CO5611133A2 (de)
DE (1) DE60308836T2 (de)
DK (1) DK1482936T3 (de)
EC (1) ECSP045277A (de)
EG (1) EG24403A (de)
ES (1) ES2274214T3 (de)
IL (2) IL163657A0 (de)
MX (1) MXPA04008571A (de)
MY (1) MY137563A (de)
NO (1) NO20044092L (de)
NZ (1) NZ534690A (de)
PE (1) PE20030828A1 (de)
PL (1) PL210870B1 (de)
PT (1) PT1482936E (de)
RU (1) RU2322982C2 (de)
TW (1) TW200305437A (de)
WO (1) WO2003074054A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05000632A (es) 2002-07-15 2005-03-31 Alcon Inc Composiciones para implante farmaceuticas, lipofilas, no polimericas para uso intraocular.
CN101897662B (zh) * 2002-07-23 2013-05-22 诺瓦提斯公司 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (de) 2009-04-09 2010-10-13 Nestec S.A. Getränkezubereitungsvorrichtung mit einem Verschlussmechanismus mit Mitteln zur starken Abnahme der Kraft
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
DK2429510T3 (en) 2009-05-12 2015-09-28 Galenica Ab The oil-in-water emulsion mometasone and propylene glycol
US8927009B2 (en) * 2009-12-22 2015-01-06 Abbvie Inc. ABT-263 capsule
RU2437647C2 (ru) * 2010-02-27 2011-12-27 Пшеничников Виталий Георгиевич Фармацевтическая композиция, обладающая антибактериальным, противовирусным и противогрибковым действием
KR20130041803A (ko) * 2010-04-07 2013-04-25 알러간, 인코포레이티드 안과 조성물을 위한 보존제의 조합
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
HK1216146A1 (zh) * 2013-03-27 2016-10-21 Comprehensive Drug Enterprises, Ltd. 眼药组合物、其制备方法及用途
CN105792848B (zh) * 2013-11-29 2021-04-09 乐敦制药株式会社 眼科用或耳鼻科用水性组合物
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (de) 2019-05-21 2020-11-25 Premark Pharma GmbH Behandlung von augenerkrankungen
JP2026512999A (ja) * 2023-01-31 2026-04-22 ウィンストン メディカル サプライ カンパニー リミテッド 点眼油剤型の医薬組成物
CN121263183A (zh) 2023-04-06 2026-01-02 普利马克制药有限责任公司 吡美莫司用于治疗患者的特征在于牛津分级量表角膜染色评分为4或5分的干眼症的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA905202B (en) * 1989-07-05 1991-04-24 Fujisawa Pharmaceutical Co Aqueous liquid composition for external use
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
US5496811A (en) * 1992-08-28 1996-03-05 Pharmos Corp. Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
JPH08502759A (ja) * 1993-08-18 1996-03-26 アルコン ラボラトリーズ，インコーポレイテッド 緑内障治療用のエルゴリン誘導体の使用
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
DK0786986T3 (da) * 1994-10-26 2002-04-29 Novartis Ag Anvendelse af en umættet fedtalkohol
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
EP0737471A3 (de) * 1995-04-10 2000-12-06 L'oreal Verwendung von Erdalkalimetallsalze als TNF-alpha Inhibitor in einer topischen Zusammensetzung und die so hergestellte Zusammensetzung
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
TR200003108T2 (tr) * 1998-04-27 2001-02-21 Fujisawa Pharmaceutical Co., Ltd. İlaç kompozisyonları
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
CZ20013769A3 (cs) * 1999-04-30 2002-03-13 Sucampo Ag Činidlo pro léčbu suchého oka

Also Published As

Publication number Publication date
TW200305437A (en) 2003-11-01
AU2003218679B2 (en) 2007-04-05
EP1482936B1 (de) 2006-10-04
EG24403A (en) 2009-04-29
US20120015971A1 (en) 2012-01-19
CO5611133A2 (es) 2006-02-28
KR100992948B1 (ko) 2010-11-08
US20110152307A1 (en) 2011-06-23
KR20040094718A (ko) 2004-11-10
JP4740542B2 (ja) 2011-08-03
NO20044092L (no) 2004-09-27
JP2005529851A (ja) 2005-10-06
ECSP045277A (es) 2004-10-26
DK1482936T3 (da) 2007-01-08
RU2004129593A (ru) 2005-09-10
ES2274214T3 (es) 2007-05-16
DE60308836T2 (de) 2007-04-26
CN1297270C (zh) 2007-01-31
AR038628A1 (es) 2005-01-19
PL210870B1 (pl) 2012-03-30
MXPA04008571A (es) 2004-12-06
BR0308184A (pt) 2005-01-11
US20100113501A1 (en) 2010-05-06
CA2477769C (en) 2011-01-18
CN1638769A (zh) 2005-07-13
HK1071301A1 (en) 2005-07-15
PT1482936E (pt) 2007-01-31
AU2003218679A1 (en) 2003-09-16
PL370917A1 (en) 2005-06-13
CA2477769A1 (en) 2003-09-12
WO2003074054A1 (en) 2003-09-12
PE20030828A1 (es) 2003-11-04
EP1482936A1 (de) 2004-12-08
IL163657A0 (en) 2005-12-18
NZ534690A (en) 2007-06-29
US20050220823A1 (en) 2005-10-06
MY137563A (en) 2009-02-27
DE60308836D1 (de) 2006-11-16
IL163657A (en) 2009-11-18
RU2322982C2 (ru) 2008-04-27

Similar Documents

Publication Publication Date Title
DE60327864D1 (de) Ballondissektor mit kanüle
DE602004020183D1 (de) Schrittmacher mit av-intervall-optimierung
DE50311697D1 (de) Zwischenwirbelimplantat mit kalottenartigen gelenkflächen
DE60319848D1 (de) Medikament mit mesenchym-stammzellen
DE60308836D1 (de) Ophthalmische zubereitung mit ascomycin
IS8043A (is) Gervigras
DE60311076D1 (de) Nanostrukturen mit pilin-protein
DE50311234D1 (de) Zwischenwirbelimplantat mit temporären blockiermitteln
DE60308332D1 (de) Chinazolinverbindungen mit therapeutischem nutzen
DE60234840D1 (de) Ascomycin enthaltende ophthalmische zubereitungen
ATE472576T1 (de) Polyalkenamine mit verbesserten anwendungseigenschaften
DE602004006816D1 (de) Ladegerät
EP1494530A4 (de) Kombinationstherapie mit kleepeptiden
DE50308359D1 (de) Armlehne
DE50308343D1 (de) Armlehne
DE60238111D1 (de) Viszeralfettmesser mit tonometer
DE602004014252D1 (de) Avermectinmonosaccharidderivate mit pestiziden eigenschaften
SE0300137L (sv) Infusionssats
DE60322421D1 (de) Verbesserter brillenbügel
DE60328921D1 (de) Kondom mit integriertem wulstaufbau
DE602004032351D1 (de) Kulierstrick- oder kulierwirkmaschine mit bewegbarer platine
DE60311138D1 (de) Pll mit symmetrischem quadrikorrelator
DE602004000838D1 (de) Intraokularlinse
AU2002100221A4 (en) The lean pole
DE602004024223D1 (de) Drehscheibe mit positionseinstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1482936

Country of ref document: EP